XML 27 R6.htm IDEA: XBRL DOCUMENT v3.23.3
BETTER 10Q - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Notes Receivables from Stockholders
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020 107,634,678          
Beginning balance at Dec. 31, 2020 $ 409,688          
Ending balance (in shares) at Dec. 31, 2021 108,721,433          
Ending balance at Dec. 31, 2021 $ 436,280          
Beginning balance (in shares) at Dec. 31, 2020   81,239,084        
Beginning balance at Dec. 31, 2020 49,326 $ 8 $ (365) $ 42,301 $ 7,522 $ (140)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   19,433,510        
Issuance of common stock 57,062 $ 2   57,060    
Repurchase or cancellation of common stock (in shares)   (1,605,435)        
Repurchase or cancellation of common stock (5,648)     (5,648)    
Stock-based compensation 64,187     64,187    
Vesting of common stock issued via notes receivable from stockholders (38,268)   (38,268)      
Net income (loss) (301,128)       (301,128)  
Other comprehensive loss— foreign currency translation adjustment, net of tax $ 35         35
Ending balance (in shares) at Dec. 31, 2021 99,067,159 99,067,159        
Ending balance at Dec. 31, 2021 $ 240,160 $ 10 (38,633) 571,501 (292,613) (105)
Beginning balance (in shares) at Dec. 31, 2021 108,721,433          
Beginning balance at Dec. 31, 2021 $ 436,280          
Ending balance (in shares) at Jun. 30, 2022 108,721,433          
Ending balance at Jun. 30, 2022 $ 436,280          
Beginning balance (in shares) at Dec. 31, 2021 99,067,159 99,067,159        
Beginning balance at Dec. 31, 2021 $ 240,160 $ 10 (38,633) 571,501 (292,613) (105)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   1,143,399        
Issuance of common stock 9,500     9,500    
Repurchase or cancellation of common stock (in shares)   (1,884,122)        
Repurchase or cancellation of common stock (1,483)     (1,483)    
Stock-based compensation 22,238     22,238    
Vesting of common stock issued via notes receivable from stockholders (9,770)   (9,770)      
Net income (loss) (399,252)       (399,252)  
Other comprehensive loss— foreign currency translation adjustment, net of tax (609)         (609)
Ending balance (in shares) at Jun. 30, 2022   98,326,436        
Ending balance at Jun. 30, 2022 $ (139,216) $ 10 (48,403) 601,756 (691,865) (714)
Beginning balance (in shares) at Dec. 31, 2021 108,721,433          
Beginning balance at Dec. 31, 2021 $ 436,280          
Ending balance (in shares) at Dec. 31, 2022 108,721,433          
Ending balance at Dec. 31, 2022 $ 436,280          
Beginning balance (in shares) at Dec. 31, 2021 99,067,159 99,067,159        
Beginning balance at Dec. 31, 2021 $ 240,160 $ 10 (38,633) 571,501 (292,613) (105)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   1,493,076        
Issuance of common stock 15,323     15,323    
Repurchase or cancellation of common stock (in shares)   (2,481,879)        
Repurchase or cancellation of common stock (2,804)     (2,804)    
Stock-based compensation 42,608     42,608    
Vesting of common stock issued via notes receivable from stockholders (15,267)   (15,267)      
Net income (loss) (888,802)       (888,802)  
Other comprehensive loss— foreign currency translation adjustment, net of tax $ (1,318)         (1,318)
Ending balance (in shares) at Dec. 31, 2022 98,078,356 98,078,356        
Ending balance at Dec. 31, 2022 $ (610,100) $ 10 (53,900) 626,628 (1,181,415) (1,423)
Ending balance (in shares) at Jun. 30, 2022 108,721,433          
Ending balance at Jun. 30, 2022 $ 436,280          
Ending balance (in shares) at Jun. 30, 2022   98,326,436        
Ending balance at Jun. 30, 2022 $ (139,216) $ 10 (48,403) 601,756 (691,865) (714)
Beginning balance (in shares) at Dec. 31, 2022 108,721,433          
Beginning balance at Dec. 31, 2022 $ 436,280          
Beginning balance (in shares) at Dec. 31, 2022 98,078,356 98,078,356        
Beginning balance at Dec. 31, 2022 $ (610,100) $ 10 (53,900) 626,628 (1,181,415) (1,423)
Beginning balance (in shares) at Dec. 31, 2022 108,721,433          
Beginning balance at Dec. 31, 2022 $ 436,280          
Ending balance (in shares) at Jun. 30, 2023 108,721,433          
Ending balance at Jun. 30, 2023 $ 436,280          
Beginning balance (in shares) at Dec. 31, 2022 98,078,356 98,078,356        
Beginning balance at Dec. 31, 2022 $ (610,100) $ 10 (53,900) 626,628 (1,181,415) (1,423)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares)   441,231        
Issuance of common stock 2,206     2,206    
Repurchase or cancellation of common stock (in shares)   (149,095)        
Repurchase or cancellation of common stock (8)     (8)    
Stock-based compensation 13,725     13,725    
Vesting of common stock issued via notes receivable from stockholders (2,354)   (2,354)      
Net income (loss) (135,408)       (135,408)  
Other comprehensive loss— foreign currency translation adjustment, net of tax $ (309)         (309)
Ending balance (in shares) at Jun. 30, 2023 98,370,492 98,370,492        
Ending balance at Jun. 30, 2023 $ (732,248) $ 10 (56,254) 642,551 (1,316,823) (1,732)
Ending balance (in shares) at Jun. 30, 2023 108,721,433          
Ending balance at Jun. 30, 2023 $ 436,280          
Ending balance (in shares) at Jun. 30, 2023 98,370,492 98,370,492        
Ending balance at Jun. 30, 2023 $ (732,248) $ 10 $ (56,254) $ 642,551 $ (1,316,823) $ (1,732)